Literature DB >> 12379469

Benzo[a]pyrene diol epoxide-deoxyguanosine adducts are accurately bypassed by yeast DNA polymerase zeta in vitro.

Srilatha Simhadri1, Pavel Kramata, Barbara Zajc, Jane M Sayer, Donald M Jerina, David C Hinkle, Caroline S-J Wei.   

Abstract

The possible role of bypass DNA polymerase zeta in mutagenic translesion synthesis past benzo[a]pyrene (BP) 7,8-diol-9,10-epoxide (DE) N(2)-deoxyguanosine (dG) adducts has been examined. We prepared 59-mer DNA templates containing dG adducts derived from trans opening of enantiomers of BP DE-2, in which the 7-hydroxyl group and epoxide oxygen are trans. The 10S-BP DE-dG and 10R-BP DE-dG adducts derive from the (+)- and (-)-DE-2 enantiomers, respectively. The adducted dG is located at a site identified as a G-->T mutational hotspot in random mutagenesis studies of (+)-BP DE-2 in Chinese hamster V-79 cells. Yeast pol zeta (complex of Gst-Rev3p and Rev7p) formed extension products (total of all lengths) of 71, 74 and 88% of a primer annealed to the 10S-BP DE-dG, 10R-BP DE-dG and non-adducted 59-mer templates, respectively. However, only 18 and 19% of the primer was extended to the full-length product on 10S-BP DE-dG and 10R-BP DE-dG adducted templates compared to 55% of the primer on the non-adducted template. A major 34-mer product corresponding to primer elongation up to and including the base before the adduct indicated that nucleotide incorporation opposite both adducts was strongly blocked. Full-length products were isolated from gels and subjected to PCR amplification and cloning. Sequence analysis of more than 300 clones of these full-length products on each template showed that only the correct dCMP was incorporated opposite both the adducted and non-adducted G-hotspot in the template. This corresponds to a probability of mutation lower than 0.3%, the limit of detection, and demonstrates the remarkable fidelity of yeast pol zeta in translesion synthesis past these BP DB-dG lesions in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379469     DOI: 10.1016/s0027-5107(02)00211-7

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Translesion replication of benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyadenosine and deoxyguanosine by human DNA polymerase iota.

Authors:  Ekaterina G Frank; Jane M Sayer; Heiko Kroth; Eiji Ohashi; Haruo Ohmori; Donald M Jerina; Roger Woodgate
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Ancient phylogenetic beginnings of immunoglobulin hypermutation.

Authors:  Jaroslav Kubrycht; Karel Sigler; Michal Růzicka; Pavel Soucek; Jirí Borecký; Petr Jezek
Journal:  J Mol Evol       Date:  2006-10-06       Impact factor: 2.395

3.  A novel function of DNA polymerase zeta regulated by PCNA.

Authors:  Matthew R Northam; Parie Garg; Dmitri M Baitin; Peter M J Burgers; Polina V Shcherbakova
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

4.  Participation of DNA polymerase zeta in replication of undamaged DNA in Saccharomyces cerevisiae.

Authors:  Matthew R Northam; Heather A Robinson; Olga V Kochenova; Polina V Shcherbakova
Journal:  Genetics       Date:  2009-10-19       Impact factor: 4.562

5.  Emergence of DNA polymerase ε antimutators that escape error-induced extinction in yeast.

Authors:  Lindsey N Williams; Alan J Herr; Bradley D Preston
Journal:  Genetics       Date:  2013-01-10       Impact factor: 4.562

6.  The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.

Authors:  Dhrubajyoti Chakravarti; Divya Venugopal; Paula C Mailander; Jane L Meza; Sheila Higginbotham; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Mutat Res       Date:  2007-09-07       Impact factor: 2.433

7.  DNA polymerase eta participates in the mutagenic bypass of adducts induced by benzo[a]pyrene diol epoxide in mammalian cells.

Authors:  Alden C Klarer; L Jay Stallons; Tom J Burke; Robert L Skaggs; W Glenn McGregor
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.